The clinical phenotype of non-small cell lung cancer (NSCLC) with the fusion gene echinoderm microtubule associated protein like 4 (EML4) - anaplastic lymphoma kinase (ALK), is characterised by early metastasis and poor prognosis in comparison to tumours without a known oncogenic driver [1]. This evidence concerns the gene ALK and non-small cell lung carcinoma.